U.S. Blood Pressure Monitoring Devices Market (By Product: Digital Blood Pressure Monitor, Sphygmomanometer, Ambulatory Blood Pressure Monitor, Instruments & Accessories, Transducers; By End User: Ambulatory Surgical Centers & Clinics, Hospitals, Home Healthcare) - Regional Outlook and Forecast 2024 to 2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Blood Pressure Monitoring Devices Market
5.1. COVID-19 Landscape: U.S. Blood Pressure Monitoring Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8.U.S. Blood Pressure Monitoring Devices Market, By Product
8.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by Product, 2024-2033
8.1.1. Digital Blood Pressure Monitor
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Sphygmomanometer
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Ambulatory Blood Pressure Monitor
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Instruments & Accessories
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Transducers
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. U.S. Blood Pressure Monitoring Devices Market, By End User
9.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by End User, 2024-2033
9.1.1. Ambulatory Surgical Centers & Clinics
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Home Healthcare
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. U.S. Blood Pressure Monitoring Devices Market and Trend Forecast
10.1. U.S.
10.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.1.2. Market Revenue and Volume Forecast, by End User (2021-2033)
Chapter 11. Company Profiles
11.1. Koninklijke Philips N.V.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. General Electric Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. SunTech Medical, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Welch Allyn
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. American Diagnostic Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Briggs Healthcare
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Spacelabs Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. GF HEALTH PRODUCTS, INC.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Rossmax International Limited
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Microlife Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client